Sarah Doernberg, MD

Infectious disease physician

Dr. Sarah Doernberg is an infectious disease specialist who sees patients at UCSF Medical Center.

She earned a medical degree at the Yale University School of Medicine and completed an internal medicine residency and an infectious disease fellowship at UCSF. She also earned a master's degree in advanced studies through the Training in Clinical Research Program at UCSF. In her research, she focuses on health care-acquired infections and preventing the development of drug-resistant microorganisms such as bacteria and fungi. She is an assistant clinical professor of medicine in Infectious Diseases and Hospital Medicine.

Clinics

Infectious Disease at Parnassus
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143-0327
Phone: (415) 353-2626
Fax: (415) 353-2568

Hours: Thursday
8:20 – 11:40 a.m.

Polycystic Kidney Disease (PKD) Center of Excellence
400 Parnassus Ave., B1 Plaza Level
San Francisco, CA 94143
Phone: (415) 514-2381

Hours: Monday to Friday,
9 a.m. - 5 p.m.

Board Certification

Infectious Disease, American Board of Internal Medicine
Internal Medicine, American Board of Internal Medicine

Academic Title

Associate Professor

More about Sarah Doernberg

Education

Yale University School of Medicine 2006

Residencies

UCSF Medical Center 2009

Fellowships

UCSF Medical Center 2011

Selected Research and Publications

  1. Wilson MR, O'Donovan BD, Gelfand JM, Sample HA, Chow FC, Betjemann JP, Shah MP, Richie MB, Gorman MP, Hajj-Ali RA, Calabrese LH, Zorn KC, Chow ED, Greenlee JE, Blum JH, Green G, Khan LM, Banerji D, Langelier C, Bryson-Cahn C, Harrington W, Lingappa JR, Shanbhag NM, Green AJ, Brew BJ, Soldatos A, Strnad L, Doernberg SB, Jay CA, Douglas V, Josephson SA, DeRisi JL. Chronic Meningitis Investigated via Metagenomic Next-Generation Sequencing. JAMA Neurol. 2018 Apr 16.
  2. Fung M, Schwartz BS, Doernberg SB, Langelier C, Lo M, Graff L, Tan M, Logan AC, Chin-Hong P, Babik JM. Breakthrough Invasive Fungal Infections on Isavuconazole Prophylaxis and Treatment: What is Happening in the Real-world Setting? Clin Infect Dis. 2018 Mar 31.
  3. Trang TP, Whalen M, Hilts-Horeczko A, Doernberg SB, Liu C. Comparative effectiveness of aerosolized versus oral ribavirin for the treatment of respiratory syncytial virus infections: A single-center retrospective cohort study and review of the literature. Transpl Infect Dis. 2018 Apr; 20(2):e12844.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.